Screening for lung cancer

New England Journal of Medicine

Volumn 343, Issue 22, 2000, Pages 1627-1633

  Patz, Edward F ^a   Goodman, Philip C ^a   Bepler, Gerold ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; LUNG CANCER; PRIORITY JOURNAL; REVIEW; SCREENING TEST; THORAX RADIOGRAPHY;

CLINICAL TRIALS; HUMANS; LUNG NEOPLASMS; MASS SCREENING; PROBABILITY; SENSITIVITY AND SPECIFICITY; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034735834     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200011303432208     Document Type: Review

References (52)

1. Cancer statistics, 1998
2. Cancer screening: Degrees of proof and practical application
3. Screening for disease
4. The Philadelphia Pulmonary Neoplasm Research Project: Early roentgenographic appearance of bronchogenic carcinoma
5. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: A cooperative pilot study of the American Cancer Society and the Veterans Administration
6. Results of lung cancer screening programs in Japan
7. South London Lung Cancer Study
8. The value of lung cancer detection by six-monthly chest radiographs
9. A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR
10. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study
11. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in Memorial Sloan-Kettering study
12. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study
13. Lung cancer detection: Results of a randomized prospective study in Czechoslovakia
14. The National Cancer Institute Cooperative Early Lung Cancer Detection Program: Results of the initial screen (prevalence): Early lung cancer detection: Introduction
15. The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: A status report
16. Survival and mortality from lung cancer in a screened population: The Johns Hopkins Study
17. Screening for lung cancer: A critique of the Mayo Lung Project
18. Current status of screening for lung cancer
19. Screening of lung cancer: Another look: A different view
20. Early detection of lung cancer: Today's approach
21. Lung cancer screening and the surgical oncologist: The controversy
22. Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography
23. Mass screening for lung cancer with mobile spiral computed tomography scanner
24. Early Lung Cancer Action Project: Overall design and findings from baseline screening
25. American College of Radiology Imaging Network: New national cooperative group for conducting clinical trials of medical imaging technologies
26. Early detection of lung cancer
27. Prospective detection of preclinical lung cancer: Results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression
28. Molecular pathogenesis of lung cancer
29. Early diagnosis of lung cancer
30. New approaches to the integrated management of early lung cancer
31. Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer
32. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: A new approach to early lung cancer detection
33. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer
34. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy
35. Malignancy associated changes in bronchial epithelial cells and clinical applications as a biomarker
36. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer
37. Revisions in the International System for Staging Lung Cancer
38. Classification of isolated tumor cells and micrometastasis
39. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer
40. Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis
41. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma
42. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer
43. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients
44. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
45. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma
46. Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity
47. Clinical applications of research on angiogenesis
48. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy
49. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation
50. Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression
51. Selection bias in trials of transplantation for metastatic breast cancer: Have we picked the apple before it was ripe?
52. The Swan-Ganz catheter: Requesting scientific trials is not an "assault"